InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Explore the detailed record of transactions filed by Schuyler Kevin, 董事. Director active across 3 companies, notably Adial Pharmaceuticals, INC.. In total, 10 disclosures have been logged. Breakdown: 6 buys · 0 sell. Total volume traded: €47k. History available since 23 December 2021. The latest transaction was disclosed on 7 April 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 条申报中的 10 条
Schuyler Kevin is Administrateur at Forza X1, Inc., Adial Pharmaceuticals, INC. and Twin Vee PowerCats, Co. He has 10 filings in total, and across the 10 sampled filings between 2021-12-23 and 2026-04-09, they are acquisitions for a total of EUR 46701 and no sales.